Extended-Spectrum β-Lactamase-Producing Enterobacterales Shedding by Dogs and Cats Hospitalized in an Emergency and Critical Care Department of a Veterinary Teaching Hospital
- PMID: 32867088
- PMCID: PMC7557403
- DOI: 10.3390/antibiotics9090545
Extended-Spectrum β-Lactamase-Producing Enterobacterales Shedding by Dogs and Cats Hospitalized in an Emergency and Critical Care Department of a Veterinary Teaching Hospital
Abstract
Extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) gut shedding in human medicine is considered as a major reservoir for ESBL-associated infections in high risk patients. In veterinary medicine, data regarding ESBL-PE gut shedding on admission to emergency and critical care department is scarce. We aimed to determine ESBL-PE shedding rates by dogs and cats in this setting and to determine the risk factors for shedding, at two separate periods, three-years apart. Rectal swabs were collected from animals, on admission and 72 h post admission, enriched and plated on Chromagar ESBL plates, followed by bacterial identification. ESBL phenotype was confirmed and antibiotic susceptibility profiles were determined (Vitek 2). Medical records were reviewed for risk factor analysis (SPSS). Overall, 248 animals were sampled, including 108 animals on period I (2015-2016) and 140 animals on period II (2019). In both periods combined, 21.4% of animals shed ESBL-PE on admission, and shedding rates increased significantly during hospitalization (53.7%, p-value < 0.001). The main ESBL-PE species were Escherichia coli and Klebsiella pneumoniae, accounting for more than 85% of the isolates. In a multivariable analysis, previous hospitalization was a risk factor for ESBL-PE gut shedding (p-value = 0.01, Odds ratio = 3.05, 95% Confidence interval 1.28-7.27). Our findings demonstrate significant ESBL-PE gut shedding among small animals in the emergency and critical care department, posing the necessity to design and implement control measures to prevent transmission and optimize antibiotic therapy in this setting.
Keywords: ESBL-PE; antibiotic resistance; companion animals; emergency and critical care.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


References
-
- Biehl L.M., Schmidt-Hieber M., Liss B., Cornely O.A., Vehreschild M.J.G.T. Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients—Review of the literature from a clinical perspective. Crit. Rev. Microbiol. 2016;42:1–16. doi: 10.3109/1040841X.2013.875515. - DOI - PubMed
-
- Bert F., Larroque B., Paugam-Burtz C., Dondero F., Durand F., Marcon E., Belghiti J., Moreau R., Nicolas-Chanoine M.-H. Pretransplant fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae and infection after liver transplant, France. Emerg. Infect. Dis. 2012;18:908–916. doi: 10.3201/eid1806.110139. - DOI - PMC - PubMed
-
- Liss B.J., Vehreschild J.J., Cornely O.A., Hallek M., Fätkenheuer G., Wisplinghoff H., Seifert H., Vehreschild M.J.G.T. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 2012;40:613–619. doi: 10.1007/s15010-012-0269-y. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous